PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 01/03/2013 -- Zogenix, Inc. (NASDAQ:ZGNX) stock climbed 6.58% to $1.48 after the company announced positive early stage results for Relday, an investigational compound of a proprietary, once-monthly subcutaneous formulation of risperidone for the treatment of schizophrenia. The company said adverse effects were mild to moderate and consistent with other risperidone products.
How To Trade ZGNX After The Recent Momentum? Find Out Here
BG Medicine, Inc. (NASDAQ:BGMD) is up over 29 percent to $3.00 following the news that the first automated version of the BGM Galectin-3(R) blood test has obtained a CE Mark, an important step in its commercial strategy.BG Medicine, Inc. (NGM:BGMD) is +0.4699 - +20.25% from the previous close of $2.32. It traded between $2.70 - 3.15 with total traded volume of 2267877 shares. At Current Market Price, BGMD is in the distance of +44.49% from its 50-day Moving Average price of $1.9309 and -30.66% from its 200-day Moving Average price of $4.0235.
Do you think now is a good time to buy or sell BGMD? See BGMD earnings forecast report Here
Herbalife Ltd. Co (NYSE:HLF) reported EPS in 3.869. For the Current Fiscal year, the company is expected to report EPS of 4.03. For the Next Quarter and Next Year, the company is expected to report EPS of 1.05 and 4.56 respectively. At Current Market Price, HLF is in distance of -15.44% from its 50-day Moving Average price of $41.7015 and -26.57% from its 200-day Moving Average price of $48.0222.
Will HLF Rebound After Today’s Slump? Find Out Here
Amicus Therapeutics, Inc. (NASDAQ:FOLD), a bio pharmaceutical company, today declared that John F. Crowley, Chairman and Chief Executive Officer, will present a business summary at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2013 at 3:00 p.m. PT.Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported the gain of +11.97% to $3.18 during the mid day trading session. Stock price 52 weeks high was $7.29 and 52 weeks low price was $2.47.
Do you think now is a good time to buy or sell FOLD? See FOLD earnings forecast report Here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)